Cheng, A L <br/><br/>
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.  [electronic resource] 

 -  Anticancer research   
 - 2895-900 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anticarcinogenic Agents--administration & dosage<br/>Arsenicals--adverse effects<br/>Bowen's Disease--chemically induced<br/>Carcinoma, Transitional Cell--drug therapy<br/>Curcumin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Leukoplakia, Oral--drug therapy<br/>Male<br/>Metaplasia<br/>Middle Aged<br/>Neoplasm Recurrence, Local--prevention & control<br/>Precancerous Conditions--drug therapy<br/>Prospective Studies<br/>Risk<br/>Skin Neoplasms--chemically induced<br/>Stomach--pathology<br/>Stomach Neoplasms--prevention & control<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy<br/>Uterine Cervical Neoplasms--drug therapy<br/>Uterine Cervical Dysplasia--drug therapy